Trading of Lyell Immunopharma was halted at 09:33 AM EST due to "LULD pause". Lyell Immunopharma (LYEL) Insider Trading & Ownership $8.22 -0.51 (-5.89%) Closing price 04:00 PM EasternExtended Trading$7.94 -0.28 (-3.39%) As of 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyell Immunopharma (NASDAQ:LYEL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage25.10%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$449,508.40Number OfInsiders Selling(Last 12 Months)0 Get LYEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyell Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LYEL Insider Buying and Selling by Quarter Lyell Immunopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/31/2025Otis W BrawleyDirectorBuy35,640$0.56$19,958.40 3/21/2025Sumant RamachandraDirectorBuy200,000$0.58$116,000.00 3/17/2025Charles W NewtonCFOBuy200,000$0.56$112,000.00 3/14/2025Lynn SeelyCEOBuy175,000$0.61$106,750.00 3/14/2025Richard KlausnerDirectorBuy158,000$0.60$94,800.00 (Data available from 1/1/2013 forward) LYEL Insider Trading Activity - Frequently Asked Questions Who is on Lyell Immunopharma's Insider Roster? The list of insiders at Lyell Immunopharma includes Charles W Newton, Lynn Seely, Otis W Brawley, Richard Klausner, and Sumant Ramachandra. Learn more on insiders at LYEL. What percentage of Lyell Immunopharma stock is owned by insiders? 25.10% of Lyell Immunopharma stock is owned by insiders. Learn more on LYEL's insider holdings. Which Lyell Immunopharma insiders have been buying company stock? The following insiders have purchased LYEL shares in the last 24 months: Charles W Newton ($112,000.00), Lynn Seely ($106,750.00), Otis W Brawley ($19,958.40), Richard Klausner ($94,800.00), and Sumant Ramachandra ($116,000.00). How much insider buying is happening at Lyell Immunopharma? Insiders have purchased a total of 768,640 LYEL shares in the last 24 months for a total of $449,508.40 bought. Lyell Immunopharma Key ExecutivesDr. Richard D. Klausner M.D. (Age 72)Founder & Executive Chairman Compensation: $80kDr. Lynn Seely M.D. (Age 65)Ph.D., President, CEO & Director Compensation: $962.23kMr. Charles W. Newton (Age 53)Chief Financial Officer Compensation: $744.74k1 recent tradesMr. Stephen J. Hill (Age 54)Chief Operating Officer Compensation: $775.97kDr. Gary Lee Ph.D. (Age 47)Chief Scientific Officer Compensation: $889.68kMr. Matthew Lang J.D. (Age 48)Chief Business Officer, Chief Legal Officer & Corporate Secretary Compensation: $596.25kProf. Stanley R. Riddell M.D.Founder & Scientific AdvisorDr. Crystal L. Mackall M.D. (Age 63)Founder & Scientific Advisor Nellie DilleryDirector of AccountingMs. Ellen RoseSenior Vice President of Communications & Investor Relations More Insider Trading Tools from MarketBeat Related Companies TYRA Insider Selling UPB Insider Selling KURA Insider Selling RGNX Insider Selling ARVN Insider Selling AMLX Insider Selling ZVRA Insider Selling ALT Insider Selling CGEM Insider Selling ORIC Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Dividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals This page (NASDAQ:LYEL) was last updated on 6/2/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Gold analyst, Sean Brodrick, gave everyday investors an advance notice of this historic surge. When the bul...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.